Literature DB >> 12195640

Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden).

Annekatrin Lukanova1, Stefan Söderberg, Pär Stattin, Richard Palmqvist, Eva Lundin, Carine Biessy, Sabina Rinaldi, Elio Riboli, Göran Hallmans, Rudolf Kaaks.   

Abstract

OBJECTIVE: In this study we test the hypothesis of a nonlinear relationship of IGF-I with indices of body fat such as body mass index (BMI), insulin, and leptin.
METHODS: The controls used in three case-control cancer studies nested in the Northern Sweden Health and Disease Cohort, were combined for this analysis. Measurements of plasma IGF-I, IGFBP-3, insulin, and leptin were available for 445 men and 391 women.
RESULTS: In both men and women we found the highest mean IGF-I levels in subjects with BMI between 24 and 26. IGF-I concentrations decreased toward BMI < or = 20 and BMI > 30 in men; however, the results for women did not reach statistical significance. The molar ratio of IGF-I/IGFBP-3 showed a similar profile to that of IGF-I, although much less pronounced. The observed peak mean IGF-I levels in the second quintiles of insulin and leptin in men supported these findings. No significant variation of mean IGF-I levels across quintiles of insulin and leptin were observed in women.
CONCLUSIONS: The results of this study provide evidence that IGF-I plasma concentrations vary substantially over a wide range of body weight and that the relationship is nonlinear.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195640     DOI: 10.1023/a:1016392129279

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  20 in total

Review 1.  Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Authors:  David R Clemmons
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06       Impact factor: 4.741

2.  Beyond waist circumference in an adult male population of Southern Italy: Is there any role for subscapular skinfold thickness in the relationship between insulin-like growth factor-I system and metabolic parameters?

Authors:  S Savastano; A Barbato; C Di Somma; B Guida; G Pizza; L Barrea; S Avallone; M Schiano di Cola; P Strazzullo; A Colao
Journal:  J Endocrinol Invest       Date:  2012-07-09       Impact factor: 4.256

Review 3.  IGF-I/IGFBP system: metabolism outline and physical exercise.

Authors:  R Gatti; E F De Palo; G Antonelli; P Spinella
Journal:  J Endocrinol Invest       Date:  2012-06-18       Impact factor: 4.256

4.  Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender.

Authors:  Jessica M Faupel-Badger; David Berrigan; Rachel Ballard-Barbash; Nancy Potischman
Journal:  Ann Epidemiol       Date:  2009-12       Impact factor: 3.797

5.  IGF-I overexpression does not promote compensatory islet cell growth in diet-induced obesity.

Authors:  Katie Robertson; Jing Dong; Kristine De Jesus; Jun-Li Liu
Journal:  Endocrine       Date:  2009-10-30       Impact factor: 3.633

6.  Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity.

Authors:  Silvia Savastano; Luigi Angrisani; Carolina Di Somma; Francesca Rota; Maria Cristina Savanelli; Teresa Cascella; Francesco Orio; Gaetano Lombardi; Annamaria Colao
Journal:  Obes Surg       Date:  2009-07-28       Impact factor: 4.129

7.  Obesity provides a permissive milieu in inflammation-associated carcinogenesis: analysis of insulin and IGF pathways.

Authors:  Nomeli P Nunez; Stephen D Hursting; Shoshana Yakar; Dan Fowler; Charles Vinson
Journal:  Methods Mol Biol       Date:  2009

8.  Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.

Authors:  Vinayak Nagaraja; Guy D Eslick
Journal:  J Gastrointest Oncol       Date:  2014-02

9.  Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.

Authors:  A L Utz; A Yamamoto; P Sluss; J Breu; K K Miller
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

10.  Effects of Behavioral Weight Loss and Metformin on IGFs in Cancer Survivors: A Randomized Trial.

Authors:  Hsin-Chieh Yeh; Nisa M Maruthur; Nae-Yuh Wang; Gerald J Jerome; Arlene T Dalcin; Eva Tseng; Karen White; Edgar R Miller; Stephen P Juraschek; Noel T Mueller; Jeanne Charleston; Nowella Durkin; Ahmed Hassoon; Dina G Lansey; Norma F Kanarek; Michael A Carducci; Lawrence J Appel
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.